Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Resino

Showing results (331-340 of 418) with videos related to

Pageof 42
Sort By:
Plos One|May 10, 2018
The IL7RA rs6897932 polymorphism is associated with progression of liver fibrosis in patients with chronic hepatitis C: Repeated measurements designMaría Ángeles Jiménez-Sousa, Ana Zaida Gómez-Moreno, Daniel Pineda-Tenor, et al.
The Journal of Infection|July 22, 2014
Mitochondrial DNA haplogroups are associated with severe sepsis and mortality in patients who underwent major surgeryMaria Angeles Jiménez-Sousa, Eduardo Tamayo, María Guzmán-Fulgencio, et al.
European Journal of Public Health|April 22, 2023
Epidemiology of bacterial co-infections and risk factors in COVID-19-hospitalized patients in Spain: a nationwide studyR López-Herrero, L Sánchez-de Prada, A Tamayo-Velasco, et al.
Frontiers in Immunology|September 9, 2021
HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected PatientsÓscar Brochado-Kith, Isidoro Martínez, Juan Berenguer, et al.
Journal of Infection and Public Health|October 1, 2025
Long-term effects of HCV eradication on lipid profiles associated with MASLD among people with HIV with advanced fibrosis or cirrhosisAna Virseda-Berdices, Belen Requena, Juan Berenguer, et al.
Frontiers in Immunology|July 15, 2026
Lipidomics of HIV/HCV-related liver decompensation: association between plasma lipid depletion and immune dysregulationRaquel Behar-Lagares, Belen Requena, Juan Berenguer, et al.
Frontiers in Pharmacology|February 4, 2022
<i>DBP</i> rs7041 and <i>DHCR7</i> rs3829251 are Linked to CD4<sup>+</sup> Recovery in HIV Patients on Antiretroviral TherapySalvador Resino, María Ángeles Jiménez-Sousa, Julià Blanco, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 15, 2022
Metabolomic changes after DAAs therapy are related to the improvement of cirrhosis and inflammation in HIV/HCV-coinfected patientsAna Virseda-Berdices, David Rojo, Isidoro Martínez, et al.
Journal of Clinical Medicine|February 2, 2021
TRPM5 rs886277 Polymorphism Predicts Hepatic Fibrosis Progression in Non-Cirrhotic HCV-Infected PatientsSalvador Resino, Amanda Fernández-Rodríguez, Daniel Pineda-Tenor, et al.
Journal of Clinical Microbiology|December 31, 2025
Challenges in accurate HDV RNA quantification: inter-assay variability and the impact of thermal shockFelipe Pérez-García, Ana Virseda-Berdices, Carlos Pita-Martínez, et al.
Pageof 42

Showing results (331-340 of 418) with videos related to

Sort By:
Pageof 42
Plos One|May 10, 2018
The IL7RA rs6897932 polymorphism is associated with progression of liver fibrosis in patients with chronic hepatitis C: Repeated measurements designMaría Ángeles Jiménez-Sousa, Ana Zaida Gómez-Moreno, Daniel Pineda-Tenor, et al.
The Journal of Infection|July 22, 2014
Mitochondrial DNA haplogroups are associated with severe sepsis and mortality in patients who underwent major surgeryMaria Angeles Jiménez-Sousa, Eduardo Tamayo, María Guzmán-Fulgencio, et al.
European Journal of Public Health|April 22, 2023
Epidemiology of bacterial co-infections and risk factors in COVID-19-hospitalized patients in Spain: a nationwide studyR López-Herrero, L Sánchez-de Prada, A Tamayo-Velasco, et al.
Frontiers in Immunology|September 9, 2021
HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected PatientsÓscar Brochado-Kith, Isidoro Martínez, Juan Berenguer, et al.
Journal of Infection and Public Health|October 1, 2025
Long-term effects of HCV eradication on lipid profiles associated with MASLD among people with HIV with advanced fibrosis or cirrhosisAna Virseda-Berdices, Belen Requena, Juan Berenguer, et al.
Frontiers in Immunology|July 15, 2026
Lipidomics of HIV/HCV-related liver decompensation: association between plasma lipid depletion and immune dysregulationRaquel Behar-Lagares, Belen Requena, Juan Berenguer, et al.
Frontiers in Pharmacology|February 4, 2022
<i>DBP</i> rs7041 and <i>DHCR7</i> rs3829251 are Linked to CD4<sup>+</sup> Recovery in HIV Patients on Antiretroviral TherapySalvador Resino, María Ángeles Jiménez-Sousa, Julià Blanco, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 15, 2022
Metabolomic changes after DAAs therapy are related to the improvement of cirrhosis and inflammation in HIV/HCV-coinfected patientsAna Virseda-Berdices, David Rojo, Isidoro Martínez, et al.
Journal of Clinical Medicine|February 2, 2021
TRPM5 rs886277 Polymorphism Predicts Hepatic Fibrosis Progression in Non-Cirrhotic HCV-Infected PatientsSalvador Resino, Amanda Fernández-Rodríguez, Daniel Pineda-Tenor, et al.
Journal of Clinical Microbiology|December 31, 2025
Challenges in accurate HDV RNA quantification: inter-assay variability and the impact of thermal shockFelipe Pérez-García, Ana Virseda-Berdices, Carlos Pita-Martínez, et al.
Pageof 42